← Back to all signals
CI · Q2 2026

Cigna Group

Reported 2026-07-30
BEAT
51EarnIQ signal
↗

Confidence rising

Mild quarter-over-quarter shift

Strong revenue growth and raised 2026 guidance signal robust execution despite pharmacy membership headwinds.

  • ✓Guidance was raised, with high specificity.
  • ✓Management tone registered as confident (85/100).
  • ✓EarnIQ detected 0 potential management deflections.
Headline–confidence gap

Headline confirmed

Management confidence reinforces the reported beat.

EPS: reported vs expected-0.6%$7.78 vs $7.83
Revenue: reported vs expected-1.2%$71.6B vs $72.4B
Guidance specificityHighRaised
Market expectations supplied by Finnhub · Reported vs consensus estimate

Our strong second quarter results reflect continued progress against these priorities and demonstrate the effectiveness of our strategy and execution.

Premium intelligence

The evidence behind the signal

Full report
Management language

Why confidence moved

“Our strong second quarter results reflect continued progress against these priorities and demonstrate the effectiveness of our strategy and execution.”
“The Cigna Group Reports Strong Second Quarter 2026 Results, Raises 2026 Outlook”
“By harnessing technology, data and AI to deliver more personalized experiences, improve access and lower costs, we are creating greater value every day.”
Guidance specificity
90/100

High specificity

2026 outlook for adjusted income from operations increased to at least $30.45 per share, backed by segment specific pre-tax projections.

Pressure point
!

Total pharmacy customers decreased 4%

0 potential deflections detected in management communication.

Narrative break

What changed

Planned exit from the Individual and Family Plans medical business as of January 1, 2027.

Q&A evidence

Management responses

No material Q&A deflections were detected.

Key positives
  • Total revenues for the second quarter 2026 increased 7% to $71.7 billion.
  • Adjusted income from operations for the second quarter 2026 increased to $2.1 billion, or $7.78 per share.
  • Full-year 2026 adjusted income from operations outlook raised to at least $30.45 per share.
Key risks
  • Total pharmacy customers decreased 4% from December 31, 2025, reflecting expected client transitions and lower membership from health plan clients.
  • Pharmacy Benefit Services adjusted income from operations decreased 27% primarily reflecting client-focused initiatives, including large client contract renewals.
  • Planned exit from the Individual and Family Plans medical business as of January 1, 2027.
Topic velocity

Language versus prior quarter

M&ANew
CostNew
ChinaNew
MarginNew
RecordNew
iPhoneNew
Signal composition

What drove the EarnIQ score

Tone+20
Eps Beat+0
Guidance+15
New Signal+8
Miss Penalty+0
Qoq Improvement+8
Deflection Penalty+0